BR0012622A - Derivados de 3-amino-2-benzil-1-fenil-propano - Google Patents
Derivados de 3-amino-2-benzil-1-fenil-propanoInfo
- Publication number
- BR0012622A BR0012622A BR0012622-5A BR0012622A BR0012622A BR 0012622 A BR0012622 A BR 0012622A BR 0012622 A BR0012622 A BR 0012622A BR 0012622 A BR0012622 A BR 0012622A
- Authority
- BR
- Brazil
- Prior art keywords
- benzyl
- amino
- phenylpropane derivatives
- derivatives
- phenylpropane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/31—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/32—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to an acyclic carbon atom of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
- C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
- C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/56—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
- C07C215/58—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
- C07C215/62—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain the chain having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/64—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
- C07C217/66—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
- C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4021—Esters of aromatic acids (P-C aromatic linkage)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
- C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes
Abstract
"DERIVADOS DE 3-AMINO-2-BENZIL-1-FENIL-PROPANO". A invenção refere-se a derivados de 3-amino-2-benzil-1-fenil-propano, ao processo de sua respectiva fabricação, aos medicamentos contendo esses compostos, bem como ao uso dessas substâncias para a fabricação de medicamentos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19933421A DE19933421A1 (de) | 1999-07-16 | 1999-07-16 | 2-Benzyl-3-dimethylamino-1-phenyl-propanderi- vate |
PCT/EP2000/005820 WO2001005743A1 (de) | 1999-07-16 | 2000-06-23 | 3-amino-2-benzyl-1-phenyl-propanderivate |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0012622A true BR0012622A (pt) | 2002-06-11 |
Family
ID=7915037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0012622-5A BR0012622A (pt) | 1999-07-16 | 2000-06-23 | Derivados de 3-amino-2-benzil-1-fenil-propano |
Country Status (23)
Country | Link |
---|---|
US (1) | US6653508B2 (pt) |
EP (1) | EP1196373A1 (pt) |
JP (1) | JP2003505358A (pt) |
KR (1) | KR20020038690A (pt) |
CN (1) | CN1174955C (pt) |
AR (1) | AR043090A1 (pt) |
AU (1) | AU778632B2 (pt) |
BR (1) | BR0012622A (pt) |
CA (1) | CA2378723A1 (pt) |
CO (1) | CO5261540A1 (pt) |
CZ (1) | CZ2002185A3 (pt) |
DE (1) | DE19933421A1 (pt) |
HK (1) | HK1045987A1 (pt) |
HU (1) | HUP0201797A3 (pt) |
IL (2) | IL147636A0 (pt) |
MX (1) | MXPA02000577A (pt) |
NO (1) | NO20020212L (pt) |
NZ (1) | NZ517164A (pt) |
PE (1) | PE20010348A1 (pt) |
PL (1) | PL353647A1 (pt) |
SK (1) | SK412002A3 (pt) |
WO (1) | WO2001005743A1 (pt) |
ZA (1) | ZA200201276B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10059412A1 (de) * | 2000-11-30 | 2002-06-13 | Gruenenthal Gmbh | Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie der Harninkontinenz |
DE10161644A1 (de) * | 2001-12-14 | 2003-06-26 | Gruenenthal Gmbh | N,N'-disubstituierte Piperazin-Verbindungen |
DE10326097A1 (de) * | 2003-06-06 | 2005-01-05 | Grünenthal GmbH | Verfahren zur Herstellung von Dimethyl-(3-aryl-butyl)-aminverbindungen |
DE10328316A1 (de) * | 2003-06-23 | 2005-01-20 | Grünenthal GmbH | Verfahren zur Herstellung von Dimethyl-(3-aryl-buthyl)-aminverbindungen als pharmazeutische Wirkstoffe |
US7435229B2 (en) * | 2004-02-25 | 2008-10-14 | Wolf Erich W | System for transcutaneous monitoring of intracranial pressure (ICP) using near infrared (NIR) telemetry |
FR2902789A1 (fr) * | 2006-06-21 | 2007-12-28 | Genfit Sa | Derives de 1,3-diphenylpropane substitues, preparations et utilisations |
WO2008050313A1 (en) * | 2006-10-25 | 2008-05-02 | Loctite (R & D) Limited | Iminium salts and methods of preparing electron deficient olefins using such novel iminium salts |
IN2013MU03670A (pt) | 2013-11-21 | 2015-07-31 | Unimark Remedies Ltd | |
EP3571183B1 (en) * | 2017-01-20 | 2024-03-06 | The Regents of the University of California | 3-(phenyl)-2-(aminomethyl)-1-phenyl-2-propen-1-one derivatives as inhibitors of the n-terminal domain of the androgen receptor for treating prostate cancer |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE938732C (de) * | 1938-09-21 | 1956-02-09 | Siemens Ag | Elektrisch beheizter Kammer-Gluehofen mit Schutzgasfuellung |
DE901438C (de) * | 1939-02-15 | 1954-01-11 | Siemens Ag | Einrichtung zum Erzielen gleichbleibender Stueckstaerken von aus koernigem oder pulverigem Stoff gepressten Erzeugnissen, insbesondere von Briketts aus Kohle |
GB901438A (en) * | 1959-04-29 | 1962-07-18 | Merck & Co Inc | Maleamic acid derivatives |
DE1110171B (de) * | 1959-11-27 | 1961-07-06 | Hoechst Ag | Verfahren zur Herstellung substituierter Amine |
US3277165A (en) * | 1962-02-08 | 1966-10-04 | Merck & Co Inc | Fumaramic acid derivatives |
US3342829A (en) * | 1963-06-15 | 1967-09-19 | Hoechst Ag | Bis-quaternary salts of triamines and process for preparing them |
DE4426245A1 (de) | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
WO1998056752A1 (en) * | 1997-06-11 | 1998-12-17 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
-
1999
- 1999-07-16 DE DE19933421A patent/DE19933421A1/de not_active Ceased
-
2000
- 2000-06-23 SK SK41-2002A patent/SK412002A3/sk not_active Application Discontinuation
- 2000-06-23 CZ CZ2002185A patent/CZ2002185A3/cs unknown
- 2000-06-23 JP JP2001511404A patent/JP2003505358A/ja not_active Withdrawn
- 2000-06-23 AU AU58189/00A patent/AU778632B2/en not_active Ceased
- 2000-06-23 CN CNB008127875A patent/CN1174955C/zh not_active Expired - Fee Related
- 2000-06-23 EP EP00943873A patent/EP1196373A1/de not_active Withdrawn
- 2000-06-23 NZ NZ517164A patent/NZ517164A/en unknown
- 2000-06-23 PL PL00353647A patent/PL353647A1/xx not_active Application Discontinuation
- 2000-06-23 BR BR0012622-5A patent/BR0012622A/pt not_active IP Right Cessation
- 2000-06-23 IL IL14763600A patent/IL147636A0/xx active IP Right Grant
- 2000-06-23 CA CA002378723A patent/CA2378723A1/en not_active Abandoned
- 2000-06-23 MX MXPA02000577A patent/MXPA02000577A/es active IP Right Grant
- 2000-06-23 KR KR1020027000542A patent/KR20020038690A/ko not_active Application Discontinuation
- 2000-06-23 HU HU0201797A patent/HUP0201797A3/hu unknown
- 2000-06-23 WO PCT/EP2000/005820 patent/WO2001005743A1/de not_active Application Discontinuation
- 2000-07-12 AR ARP000103573A patent/AR043090A1/es not_active Application Discontinuation
- 2000-07-12 PE PE2000000692A patent/PE20010348A1/es not_active Application Discontinuation
- 2000-07-13 CO CO00052850A patent/CO5261540A1/es not_active Application Discontinuation
-
2002
- 2002-01-15 IL IL147636A patent/IL147636A/en not_active IP Right Cessation
- 2002-01-15 NO NO20020212A patent/NO20020212L/no not_active Application Discontinuation
- 2002-01-16 US US10/046,567 patent/US6653508B2/en not_active Expired - Fee Related
- 2002-02-14 ZA ZA200201276A patent/ZA200201276B/xx unknown
- 2002-10-10 HK HK02107391.8A patent/HK1045987A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
PE20010348A1 (es) | 2001-05-05 |
AU778632B2 (en) | 2004-12-16 |
NO20020212D0 (no) | 2002-01-15 |
WO2001005743A1 (de) | 2001-01-25 |
PL353647A1 (en) | 2003-12-01 |
CO5261540A1 (es) | 2003-03-31 |
CZ2002185A3 (cs) | 2002-05-15 |
SK412002A3 (en) | 2002-06-04 |
US20020161262A1 (en) | 2002-10-31 |
IL147636A (en) | 2006-08-20 |
DE19933421A1 (de) | 2001-01-25 |
AU5818900A (en) | 2001-02-05 |
CA2378723A1 (en) | 2001-01-25 |
ZA200201276B (en) | 2003-07-30 |
CN1174955C (zh) | 2004-11-10 |
AR043090A1 (es) | 2005-07-20 |
HK1045987A1 (zh) | 2002-12-20 |
EP1196373A1 (de) | 2002-04-17 |
HUP0201797A3 (en) | 2003-03-28 |
IL147636A0 (en) | 2002-08-14 |
JP2003505358A (ja) | 2003-02-12 |
NO20020212L (no) | 2002-01-15 |
KR20020038690A (ko) | 2002-05-23 |
MXPA02000577A (es) | 2003-02-27 |
US6653508B2 (en) | 2003-11-25 |
CN1373745A (zh) | 2002-10-09 |
NZ517164A (en) | 2004-02-27 |
HUP0201797A2 (hu) | 2002-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9801606B1 (pt) | composto, processo para sua preparação, substáncia farmacêutica, uso do composto e processo para a produção de uma substáncia farmacêutica. | |
PT1086092E (pt) | Derivados de 1,1-dioxido-benzo (b) tiepina processo para a sua producao medicamentos contendo esses compostos e a sua utilizacao | |
BR9807502B1 (pt) | compostos orgÂnicos, processo para sua preparaÇço, bem como composiÇço e aplicaÇço dos mesmos. | |
BR9804378B1 (pt) | compostos, processo para sua produção e uso. | |
BR9707839A (pt) | Primido-Ú5,4-D¾-primidas medicamentos contendo esses compostos sua aplicação e processo para a sua preparação | |
BR9912109B1 (pt) | compostos derivados de quinolina, composições farmacêuticas, processo para a manufatura de um composto, e, uso de um composto. | |
BR9909925B1 (pt) | derivados de quinolina, composições farmacêuticas, e, processo para a fabricação de derivados de quinolina. | |
BR9810802B1 (pt) | composto, composição farmacêutica, e, processo para a preparação de um composto. | |
BR0017030B8 (pt) | derivados de tiazolilamida, processo para sua preparação, composição farmacêutica que os compreende e uso dos mesmos | |
ID26310A (id) | Produksi kontinyu 1,3-dioksolan-2-ona | |
BR0013316A (pt) | Derivados substituìdos de 2-dialquilaminoalquilbifenila, seu processo de fabricação e seu uso. | |
FI980862A0 (fi) | Kiraalisia metyylifenyylioksatsolidinoneja | |
BR0013311A (pt) | Derivados substituìdos de 1,5-dihidropirrol-2-ona eficazes como antagonistas de receptores nmda para o tratamento de estados de dor | |
PT1033990E (pt) | 21-hidroxi-6,19-oxidoprogesterona (21oh-6op) e a sua utilizacao como medicamento para tratar o excesso de glucocorticoides | |
BR9909739A (pt) | Benzotiadiazóis e derivados | |
BR9104948A (pt) | Compostos,processo para a sua producao,agente farmaceutico e processo para a sua producao | |
BR0012622A (pt) | Derivados de 3-amino-2-benzil-1-fenil-propano | |
SE9801494D0 (sv) | Novel use | |
BRPI9914571B1 (pt) | composto, processo para sua preparação, uso do mesmo, bem como composição farmacêutica. | |
TR199900548A3 (tr) | Düsük kesme kuvvetli taneleme kullanilarak dozaj birimlerinin yapimi. | |
BR9714066B1 (pt) | processo para a preparaÇço de derivados de tiazol, bem como intermediÁrios e processos para sua preparaÇço. | |
BR0114380A (pt) | Derivados-1-aminobutan-3-ol-substituìdos | |
BR9808923A (pt) | Composto, e, processo para fazer o mesmo | |
BR0016941A (pt) | Derivados de aminometil-fenil-ciclohexanona | |
BR9800565B1 (pt) | processo para a produÇço de compostos de halogeno-o-hidroxidifenila. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A, 6A, E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1929 DE 26/12/2007. |